Equine hyperimmune serum protects mice against Clostridium difficile spore challenge

Area of Science:

• Veterinary Medicine
• Immunology
• Microbiology

Background:

• Clostridium difficile causes significant nosocomial diarrhea in horses.
• Current treatments like vancomycin and metronidazole are only moderately effective.
• There is a critical need for novel therapeutic strategies against C. difficile infections in equine populations.

Purpose of the Study:

• To develop and evaluate equine-origin antiserum for passive immunotherapy against Clostridium difficile.
• To assess the toxin-neutralizing capacity of the prepared antiserum in vitro.
• To determine the prophylactic efficacy of the hyperimmune serum in a mouse model.

Main Methods:

• Equine antiserum was prepared against Clostridium difficile toxins A and B, and whole-cell bacteria.
• In vitro assays were conducted to evaluate the toxin-neutralizing activities of the antibodies.
• A mouse model was used to demonstrate the in vivo prophylactic effects of passive immunotherapy.

Main Results:

• Immunized horses produced antibodies against Clostridium difficile toxins A and B with demonstrated toxin-neutralizing activity.
• Mice treated with equine antiserum showed reduced weight loss, absence of illness, and faster weight regain after C. difficile challenge.
• The protective effects of intravenous hyperimmune serum were observed to be dose-dependent.

Conclusions:

• Equine-origin hyperimmune serum possesses significant neutralizing activity against Clostridium difficile toxins.
• Passive immunotherapy using this antiserum offers a promising prophylactic strategy for preventing Clostridium difficile infections in animals.
• Intravenous administration of hyperimmune serum can effectively protect against C. difficile challenge in a dose-dependent manner.